Merkzettel Warenkorb
  • Produktbild: Dopamine and Glutamate in Psychiatric Disorders
  • Produktbild: Dopamine and Glutamate in Psychiatric Disorders
- 12%

Dopamine and Glutamate in Psychiatric Disorders

12% sparen

206,99 € UVP 235,39 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.12.2011

Abbildungen

XIV, 57 illus., schwarz-weiss Illustrationen

Herausgeber

Werner Schmidt + weitere

Verlag

Humana Press

Seitenzahl

600

Maße (L/B/H)

25,4/17,8/3,3 cm

Gewicht

1175 g

Auflage

2005

Sprache

Englisch

ISBN

978-1-61737-495-1

Beschreibung

Rezension

"...offers an excellent review of our understanding of how dopamine and glutamate influence the pathophysiology of psychiatric disease...an impressive effort, and every psychiatrist (and neurologist) should have this book in their reference library." - 4 Stars, Doody's Health Sciences and Book Review Journal

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.12.2011

Abbildungen

XIV, 57 illus., schwarz-weiss Illustrationen

Herausgeber

Verlag

Humana Press

Seitenzahl

600

Maße (L/B/H)

25,4/17,8/3,3 cm

Gewicht

1175 g

Auflage

2005

Sprache

Englisch

ISBN

978-1-61737-495-1

Herstelleradresse

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Dopamine and Glutamate in Psychiatric Disorders
  • Produktbild: Dopamine and Glutamate in Psychiatric Disorders
  • Part I. Dopamine

    Dopamine Receptors
    Kim A. Neve

    Dopamine Receptor Alternative Splicing
    Neil M. Richtand, Laurel M. Pritchard, and Lique M. Coolen

    Part II. Glutamate

    Glutamatergic Pathways: Their Relevance for Psychiatric Diseases
    Yoland Smith

    Glutamate Receptors: Ionotropic
    Daniel T. Monaghan, Julia C. A. More, Bihua Feng, and David E. Jane

    Metabotropic Glutamate Receptors
    Krystyna Ossowska

    Part III. Schizophrenia

    Dopamine and Schizophrenia
    Bart A. Ellenbroek

    Glutamate and Schizophrenia and the N-Methyl-d-Aspartate Receptor Hypofunction Hypothesis
    Stefan Bleich and Johannes Kornhuber

    Role of Glycine in Schizophrenia
    Beate D. Kretschmer

    Part IV. Depression

    Dopamine and Depression
    Phil Skolnick

    Glutamate and Depression
    Joaquín Del Río and Diana Frechilla

    Part V. Stress and Aggression

    Dopamine, Glutamate, and Aggression
    Klaus A. Miczek and Eric W. Fish

    Part VI. Anxiety

    Glutamatergic Systems and Anxiety
    David N. Stephens

    Part VII. Attention Deficit Hyperactivity Disorder

    Dopamine and Glutamate in Attention Deficit Hyperactivity Disorder
    James M. Swanson, Nora D. Volkow, Jeffrey Newcorn, B. J. Casey, Robert Moyzis, David K. Grandy, and Michael I. Posner

    Part VIII. Addiction

    Dopamine-Glutamate Interactions in Reward-Related Incentive Learning
    Richard J. Beninger and Todor V. Gerdjikov

    Sensitization and Relapse: Dopamine-Glutamate Interactions
    David A. Baker and Peter W. Kalivas

    Glutamatergic Neurotransmission in Sensitization
    Thomas M. Tzschentke

    Glutamatergic Mechanisms of Drug Relapse: Withdrawal and Conditioning Factors
    Anton Y. Bespalov and Robert L. Balster

    Part IX. Neurodegeneration

    Dopamine andNeurodegeneration
    Gabriele Gille and Peter Riederer

    Glutamate and Neurodegeneration
    Antonello Novelli, Marcos Pérez-Basterrechea, and Maria Teresa Fernández-Sánchez

    Part X. Parkinson's Disease

    Presymptomatic and Symptomatic Stages of Intracerebral Inclusion Body Pathology in Idiopathic Parkinson's Disease
    Heiko Braak and Kelly Del Tredici

    Dopamine and Glutamate in Parkinson's Disease: Biochemistry, Clinical Aspects, and Treatment
    Heinz Reichmann, Bernd Janetzky, and Peter Riederer

    Dopamine and Glutamate in Motor and Cognitive Symptoms of Parkinson's Disease
    Werner J. Schmidt

    Part XI. Huntington's Disease

    Dopamine and Glutamate in Huntington's Disease
    Carlos Cepeda, Marjorie A. Ariano, and Michael S. Levine

    Part XII. Dementias

    Dopaminergic and Glutamatergic Systems in Alzheimer's Disease
    Paul T. Francis

    Index